Universal-Beteiligungs- und Servicegesellschaft
JANX icon

Universal-Beteiligungs- und Servicegesellschaft’s Janux Therapeutics JANX Stock Holding History

Universal-Beteiligungs- und Servicegesellschaft’s Portfolio JANX Stock Details JANX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-46,264
Closed -$2.48M – 1993
2024
Q4 		$2.48M Buy
+46,264
New +$2.45M ﹤0.01% 856

Other funds holding JANX

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Universal-Beteiligungs- und Servicegesellschaft's JANX Position: Q1 2025 in Review

Universal-Beteiligungs- und Servicegesellschaft sold out of Janux Therapeutics (JANX) in Q1 2025, closing a stake of 46,264 shares — an estimated $2.48M sold.

Universal-Beteiligungs- und Servicegesellschaft first reported a position in JANX in Q4 2024 and held it in 1 quarter. The position peaked at $2.48M in Q4 2024. 181 funds tracked by Wall St. Rank hold JANX as of Q1 2025.

  • Universal-Beteiligungs- und Servicegesellschaft reported no remaining Janux Therapeutics position as of Q1 2025 after selling out during the quarter.
  • Universal-Beteiligungs- und Servicegesellschaft sold 46,264 Janux Therapeutics shares in Q1 2025, an estimated $2.48M.
  • Universal-Beteiligungs- und Servicegesellschaft first reported a position in Janux Therapeutics in Q4 2024 and held it in 1 quarter.
  • Universal-Beteiligungs- und Servicegesellschaft's Janux Therapeutics position peaked at $2.48M in Q4 2024.
  • 181 funds tracked by Wall St. Rank held Janux Therapeutics as of Q1 2025.

Based on Universal-Beteiligungs- und Servicegesellschaft's 13F filing for Q1 2025, filed 6 May 2025.